EFFECTIVE DELIVERY OF CROSS-SPECIES A3 ADENOSINE-RECEPTOR ANTAGONISTS TO REDUCE INTRAOCULAR PRESSURE
Mexico
MX/A/2009/003750
Filed on 2009-04-06
MX/A/2009/003750
Filed on 2009-04-06
EFFECTIVE DELIVERY OF CROSS-SPECIES A3 ADENOSINE-RECEPTOR ANTAGONISTS TO REDUCE INTRAOCULAR PRESSURE
Japan
2009531464
Filed on 2009-04-06
2009531464
Filed on 2009-04-06
EFFECTIVE DELIVERY OF CROSS-SPECIES A3 ADENOSINE-RECEPTOR ANTAGONISTS TO REDUCE INTRAOCULAR PRESSURE
European Patent
7852549
Filed on 2007-10-05
7852549
Filed on 2007-10-05
EFFECTIVE DELIVERY OF CROSS-SPECIES A3 ADENOSINE-RECEPTOR ANTAGONISTS TO REDUCE INTRAOCULAR PRESSURE
Canada
2665616
Filed on 2007-10-05
2665616
Filed on 2007-10-05
EFFECTIVE DELIVERY OF CROSS-SPECIES A3 ADENOSINE-RECEPTOR ANTAGONISTS TO REDUCE INTRAOCULAR PRESSURE
Australia
2007307157
Filed on 2007-10-05
2007307157
Filed on 2007-10-05
A3 Adenosine Receptor Agonists And Antagonists
US Patent 8,916,570
Filed on 2012-02-10
Filed on 2012-02-10
Chrysophaentin Analogs That Inhibit FTSZ Protein
Patent Cooperation Treaty
PCT/US2012/026438
Filed on 2012-02-24
PCT/US2012/026438
Filed on 2012-02-24
NOVEL ADENOSINE DERIVATIVE COMPOUND WHICH IS ABLE TO MEDIATE INFLAMMATORY DISEASES AS ADENOSINE A3 RECEPTOR ANTAGONIST
South Korea
10-2008-7031811
Filed on 2007-03-07
10-2008-7031811
Filed on 2007-03-07